减毒沙门菌载体在应激性溃疡基因治疗中的研究现状  

The Research Status of Attenuated Salmonella Carrier in Gene Therapy for Stress Ulcer

作　　者：白燕青 王娟[1] 哈小琴[1] 

机构地区：[1]兰州军区兰州总医院检验科,兰州730050 [2]甘肃重大疾病分子医学与中医药防治研究省级重点实验室,兰州730000

出　　处：《医学综述》2016年第19期3757-3760,共4页Medical Recapitulate

基　　金：甘肃省科技支撑计划-社会发展计划项目(0708NKCA128)

摘　　要：近年来基因疗法发展迅速,减毒沙门菌介导的真核表达载体防治应激性溃疡的基因治疗方法已经逐步从实验及基础研究过渡到临床试用阶段,理论和技术层次上日趋成熟。而基于低氧诱导因子1α与角质细胞生长因子防治应激性溃疡的研究现状一直缺乏整理与总结,该文整理了携带双基因的重组减毒沙门菌的实现情况及存在问题,为进一步研究提供帮助。Atpresent gene therapy has developed rapidly. Gene therapy containing the eukayotic expression vector of attenuated Salmonella has gradually transited from experiment and basic research to clinical trial stage in prevention and treatment of stress ulcer,and the theory and technology level are more and more mature. However, the keratinocyte growth factor and hypoxia-inducible factor 1α-based research of prevention of stress ulcer has been lacking of finishing with summary. Here is to summarize the achievement and problems of recombinant Salmonella carrying double genes to help the further research.

关 键 词：应激性溃疡 减毒沙门菌 低氧诱导因子1Α 角质细胞生长因子 

分 类 号：R656.6[医药卫生—外科学] Q78[医药卫生—临床医学]